AKBA
Akebia Therapeutics, Inc.
Key Financials
Operating Income
$23.5M
↑ 146.6%
Net Income
$-5345000
↑ 92.3%
Revenue
$236.2M
↑ 47.5%
Total Assets
$376.6M
↑ 70.6%
EPS (Diluted)
$-0.02
↑ 93.9%
Total Liabilities
$344.0M
↑ 27.5%
Long-term Debt
$48.3M
↑ 24.7%
Cash & Equivalents
$184.8M
↑ 256.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AKBA |
| Company Name | Akebia Therapeutics, Inc. |
| CIK | 1517022 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-871-2098 |